Medicament for curing central serous chorioretinopathy (CSCR) and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A retinopathy, serous technology, used in drug combinations, pharmaceutical formulations, cardiovascular system diseases, etc.
Inactive Publication Date: 2009-09-09
强云升
View PDF0 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, there are no clinically effective therapeutic drugs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0014] 10 grams of Poria cocos, 10 grams of Alisma orientalis, 10 grams of Salvia miltiorrhiza, 10 grams of schisandra, 5 grams of Cyperus rotundus, 5 grams of turmeric, 10 grams of Achyranthes bidentata, 10 grams of argentea, 10 grams of cicada slough, 10 grams of horsetail, 10 grams of Chinese wolfberry Grams, 5 grams of licorice.
[0015] Preparation method: Take the above-mentioned medicine and grind it into fine powder, decoct in water twice, filter, concentrate to a thick paste, dry, grind into fine powder and fill it into capsules. According to needs, the dosage form of the drug can also be one of tablets, granules, oral liquids, soft capsules, powders, mixtures, and pills.
Embodiment 2
[0017] 20 grams of Poria cocos, 15 grams of Alisma orientalis, 20 grams of Salvia, 12 grams of Schisandra, 15 grams of Cyperus rotundus, 15 grams of turmeric, 15 grams of Achyranthes, 13 grams of argentea, 13 grams of cicada, 13 grams of horsetail, 15 grams of Chinese wolfberry Grams, 10 grams of licorice.
[0018] Preparation method: Take the above-mentioned medicine and grind it into fine powder, decoct in water twice, filter, concentrate to a thick paste, dry, grind into fine powder and fill it into capsules. According to needs, the dosage form of the drug can also be one of tablets, granules, oral liquids, soft capsules, powders, mixtures, and pills.
Embodiment 3
[0020] 30 grams of Poria, 20 grams of Alisma orientalis, 20 grams of Salvia, 15 grams of Schisandra, 10 grams of Cyperus rotundus, 10 grams of turmeric, 15 grams of Achyranthes, 15 grams of Argentea, 15 grams of cicada, 15 grams of horsetail, 20 grams of Chinese wolfberry Grams, 15 grams of licorice.
[0021] Preparation method: Take the above-mentioned medicine and grind it into fine powder, decoct in water twice, filter, concentrate to a thick paste, dry, grind into fine powder and fill it into capsules. According to needs, the dosage form of the drug can also be one of tablets, granules, oral liquids, soft capsules, powders, mixtures, and pills.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicament for curing central serous chorioretinopathy (CSCR) and a preparation method thereof. The medicament is prepared from the materials in parts by weight as follows: 10g to 30g of Tuckahoe, 10g to 20g of rhizoma alismatis, 10g to 30g of salvia miltiorrhiza, 10g to 15g of shizandra berry, 5g to 20g of rhizoma cyperi, 5g to 20g of radix curcumae, 10g to 20g of radix achyranthis bidentatae, 10g to 15g of feather cockscomb seed, 10g to 15g of cicada ecdysis, 10g to 15g of horsetail, 10g to 20g of boxthorn fruit and 5g to 15g of liquorice. The method for preparing the medicament comprises the following steps: grinding the components into fine powder; decocting the components for twice; filtering; concentrating into thick paste; drying; grinding into fine powder; and packaging into capsules. By integrating the components as a whole, the medicament has the effects of activating blood, relieving depression, inducing dieresis and improving vision, thereby dilating the blood vessel, reducing the vascular resistance, increasing the peripheral blood flow, improving the microcirculation, reducing the capillary permeability, improving the metabolism of tissues, promoting the absorption of pathological changes and improving the visual function. The method has high curative effect on clinical application.
Description
Technical field [0001] The invention relates to a medicine for treating central serous chorioretinopathy and a preparation method thereof. Background technique [0002] Central serous chorioretinopathy (hereinafter referred to as medium serous), its pathogenesis is mainly caused by various reasons to increase the permeability of the choroidal vessel wall, and the exudate penetrates the abnormal pigment epithelium to reach the subretinal space, causing the macula Retinal edema, oozing. The disease is a common clinical eye disease, the cause of which is unknown so far, it mostly occurs in young adults between 20 and 45 years old, mostly in men. The main symptoms are vision loss, dark central area, reduced visual distortion, edema in the macular area of the fundus, loss of foveal light reflection, or exudate. Long course of disease, easy to relapse. At present, there is no clinically effective therapeutic drug. Summary of the invention [0003] The technical problem to be solved ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more